Valeo Pharma Inc presents at the Proactive One2One Virtual Forum - March 29th 2022

Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF), CFO, Luc Mainville, presents at the Proactive One2One Virtual Forum - March 29th 2022. Valeo Pharma is a Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Neurodegenerative Diseases, Oncology and Hospital Specialty Products. Headquartered in Kirkland, Quebec, Valeo Pharma has all the required capabilities and the full infrastructure to register and properly manage its growing product portfolio through all stages of commercialization.